Research grants

 

Epworth Research Institute grants​

 

Each year the Epworth Research Institute (ERI) awards research funding to Epworth affiliated investigators to support the conduct of investigator initiated research across Epworth HealthCare. 


The ERI grant applications are assessed, by the ERI Research Committee, on a number of criteria including but not limited to:

  • Researcher affiliation to Epworth HealthCare;
  • Alignment to the Epworth’s strategic research directions;
  • Demonstration of strategic benefit and addressing an unmet clinical need;
  • Capacity building for early and mid-career researchers;
  • Budget suitability and project milestones;
  • Scientific merit, project design and achievable outcomes;
  • Quality of the application.


Applications for the 2017 grant funding round open 01 February


The 2017 ERI grant round includes the following funding categories:

  • Strategic research grants – up to $100,000;
  • Gynaecological cancer research grants - up to $70,000;
  • Development research grants - up to $50,000;
  • Feasibility research grants - up to $10,000;
  • Pancreatic cancer research grants - up to $10,000.


To apply for a 2017 ERI grant please complete the ERI grant application form and submit with the relevant additional documents in a PDF format to research@epworth.org.au


Applications for the ERI grant funding round close 5 pm on Friday, 31 March


Complete applications must be received before 5 pm on Friday, 31 March 2017 to be considered. The successful applicants will be announced during Epworth Research Week.


For further information please contact Victoria McMorran, Research Development and Governance on 03 9936 8058 or research@epworth.org.au


Annual reporting

 

A report on the progress of the ERI grant funded research project is required to be submitted by the grant recipient each year.


Annual/final reports should be submitted to research@epworth.org.au no later than the 31 August each year using the ERI grant progress report template.


Recipients of ERI grants in 2016


The total funding awarded through the ERI grant program in 2016 was $655,000. This equalled a success rate around 40%.

 

Feasibility grant (up to $10,000 each)


Ms Jemma Keeves, physiotherapist, Epworth rehabilitation
Longitudinal prospective study of outcomes following traumatic amputation


Mr John Kenny, chief medical physicist, radiation oncology, Epworth Richmond
3D Printing applications in Radiation Oncology


Ms Catherine Abigail Oliver, chronic disease program coordinator, Epworth rehabilitation
Feasibility and impact of the New Dimensions Reconditioning Program at Epworth Camberwell


Mr Samuel Towns, senior medical physicist, Epworth Richmond
Gold Nanoparticles as a Novel Contrast Agent for Radiation Therapy


Development grants (up to $50,000 each)


Ms Michelle Kahn and Ms Megan Banky, physiotherapists, Epworth rehabilitation
Better Assessments for Better Outcomes: Revolutionising outcome measurement using innovative technologies in people with Acquired Brain Injury (ABI)


Dr Felicity Lorains, clinical neuropsychologist, Epworth rehabilitation
Pilot Randomised-Controlled-Trial comparing computer-based memory training and compensatory memory rehabilitation in Acquired Brain Injury


Dr Trisha Peel, antimicrobial stewardship physician, Epworth Richmond
Optimising Antimicrobial Use at Epworth HealthCare


Dr Diane Kelly, staff intensive care specialist, Epworth Richmond
Critical Care Interventions at the end of life: A Simulation-based study


Mr Brian Devitt, director of research OrthoSport Victoria and Fellow, Epworth Richmond
Am I doing it correctly? Optimising knee rehabilitation in the aged population through biofeedback 


Dr Kyle Brooks, staff consultant intensivist, Epworth Richmond
VEREEFY: Validation of Epworth Richmond's Echo Education Focused Year


Dr Leon Dunn, medical physicist, Epworth Richmond
Biofeedback for patient motion management in breast and lung cancer radiation therapy


Dr Daniel Croagh, hepatobiliary surgeon and interventional endoscopist, Epworth Richmond
Personalised chemotherapy in pancreatic cancer: Panitumumab for RAS wild-type pancreatic cancer as determined by EUS FNA


A/Prof Martin Richardson, department of surgery, orthopaedics, Epworth Eastern and Richmond
Echidna Pin Project: Clavicle Repair


Strategic grant (up to $100,000)


Ms Jo McDonall, research affiliate, Epworth Deakin centre for clinical nursing research, Epworth Richmond
Multimedia (MyStay) Intervention for managing patient experience (MIME) following total hip replacement surgery: a cluster randomised trial

 

Audrey Voss gynaecological cancer grant (up to $80,000)


Dr Rachel Delahunty, medical oncologist, Epworth Eastern
Circulating tumour DNA in endometrial cancer